SEC EDGAR · Company announcement
AORT: Financial results
Filed 8-K for an event or period dated 2026-11-05. Financial results.
Follow AORT- Became public
- Nov 5, 2026, 4:07 PM EST
- Event / period date
- Nov 5, 2026
- Collected
- Nov 7, 2026, 5:36 PM EST
Why this is connected
This filing identifies ARTIVION, INC. as the issuer of the security. The company's SEC identifier connects it to AORT.
Source evidence
Read the source excerpt or record
Item 2.02 Results of Operations and Financial Condition. On November 5, 2026, Artivion, Inc. (“Artivion”) issued a press release announcing its financial results for the third quarter ended September 30, 2026. Artivion hereby incorporates by reference herein the information set forth in its press release dated November 5, 2026, a copy of which is attached hereto as Exhibit 99.1. Except as otherwise provided in the press release, the press release speaks only as of the date of such press release and it shall not create any implication that the affairs of Artivion have continued unchanged since such date. The information provided pursuant to this Item 2.02, including Exhibit 99.1 attached hereto, is to be considered “furnished” pursuant to Item 2.02 of Form 8-K and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended, nor shall it be deemed incorporated by reference into any of Artivion’s reports or filings with the Securities and Exchange Commission (the “SEC”), whether made before or after the date hereof, except as expressly set forth by specific reference in such report or filing. Except for the historical information contained in this report, the statements made by Artivion are forward-looking statements that involve risks and uncertainties. All such statements are subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. Artivion’s future financial performance could differ significantly from the expectations of management and from results expressed or implied in the press release. Please refer to the last paragraph of the text portion of the press re
Congressional trading in AORT
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Sep 10, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Aug 20, 2026 · disclosed Sep 10, 2026
- Sep 4, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Jul 16, 2026 · disclosed Sep 4, 2026 · filed 50 days later
- Nov 18, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Oct 9, 2025 · disclosed Nov 18, 2025
- Nov 20, 2023$50K–$100K
Sen. Tina Smith (D-MN)
$50K–$100K · Traded Nov 16, 2023 · disclosed Nov 20, 2023 · Spouse
- Nov 20, 2023$50K–$100K
Sen. Tina Smith (D-MN)
$50K–$100K · Traded Nov 10, 2023 · disclosed Nov 20, 2023 · Spouse
- Aug 21, 2023$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
$1K–$15K · Traded Jul 14, 2023 · disclosed Aug 21, 2023 · Joint
- Jul 11, 2023$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
$1K–$15K · Traded Jun 13, 2023 · disclosed Jul 11, 2023 · Joint
- Oct 17, 2022$50K–$100K
Sen. Tina Smith (D-MN)
$50K–$100K · Traded Sep 23, 2022 · disclosed Oct 17, 2022 · Spouse
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.